The primary cilium is a solitary membrane extrusion from the apical surface of noncycling resting cells in mammals. It functions as a sensory organelle that is responsible for the resting cells to sense environmental conditions and communicate with adjacent cells. This organelle is composed of a microtubule-based axoneme encased in the plasma membrane, resulting in formation of a ciliary compartment that is separated from the cytoplasm by a transition zone at its base. Protein trafficking within the ciliary compartment is mediated by intraflagellar transport that transverses the compartment bi- directionally on the microtubules. Accumulating evidence suggests that the ability of the primary cilium to function as a sensory organelle depends on selective accumulation of various signaling molecules. Many components of cilium-dependent pathways are found to be transported into and out of the primary cilium in response to environmental cues. However, the mechanisms underlying the regulated trafficking remain unknown. The proposed application is to define a previously unknown mechanism in intraflagellar protein trafficking that as suggested by our preliminary data, regulates ciliary accumulation of soluble protein kinases in response to flow stress and chemical stimulation. This novel mechanism is mediated by folliculin (FLCN), a tumor suppressor, of which defects cause the Birt-Hogg-Dube (BHD) syndrome, a genetic disorder that is manifested clinically by benign tumors and cystic growth in multiple organs. In ciliated resting cells inactivation of FLCN produces profound effects on several major cilium-dependent pathways, including the Sonic Hedgehog (Shh) pathway, which becomes fully active and unresponsive to ligand stimulation. Preliminary data suggest that FLCN couples Shh ligand stimulation to ciliary accumulation and activation of Smoothened (Smo), a key but poorly understood step in Shh signaling. The application is proposed to define the underlying molecular basis and its functional significance in general ciliary signaling. Three lines of investigation will be carried out in the context of ligand and flow stress regulated Shh signaling. including: 1) determining how FLCN-mediated ciliary protein accumulation controls Smo activation in response to Shh ligand stimulation; 2) determining the role of Rab23 small GTPase in the ciliary function of FLCN; 3) determining how flow stress controls Shh signaling through FLCN. Successful completion of the proposed studies will offer a new paradigm to explain how ciliary signaling is regulated by environmental cues and elucidate the mechanism underlying the Shh ligand- induced activation of Smo.

Public Health Relevance

When mammalian cells exit cell cycle and enter quiescence, a majority of them forms a unique microtubule-based organelle termed the primary cilium that projects from the cell surface. This once regarded as a vestigial structure has recently been found to play a pivotal role in regulating cell differentiation, cell cycle entry, cell polarity during development and maintenance of tissue homeostasis. Defects in this organelle are associated with a large numbers of pleiotropic disease conditions in human, collectively called ciliopathy, including polycystic kidney disease, nephronophthisis, and Bardel-Biedl syndrome. The primary cilium functions as a cellular antenna for cells to sense environmental conditions and to coordinate signaling activities that dictate cell function. Its signaling activity depends on selective accumulation of various signaling molecules within the ciliary compartment that is separated from the cytoplasm. Protein trafficking into and out of the compartment is carried out by intraflagellar transport and regulated by extracellular physical and chemical signals. However, the mechanism underlying the regulated protein trafficking within the primary cilium remains largely unknown. The proposed application is to define the molecular basis for the regulated trafficking and to understand how the trafficking events of signaling molecules are integrated with their biochemical activities. Successful completion of the proposed study will provide insights into a fundamental mechanism in cell signaling and help us to understand why defects in this unique cell organelle cause a wide spectrum of pathophysiological conditions in human.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM132127-02
Application #
9935100
Study Section
Molecular and Integrative Signal Transduction Study Section (MIST)
Program Officer
Ainsztein, Alexandra M
Project Start
2019-05-24
Project End
2023-03-31
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
2
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Pharmacology
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15260